Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tito Fojo

Showing results (161-170 of 237) with videos related to

Pageof 24
Sort By:
Molecular Cancer Therapeutics|December 17, 2008
A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapyJunbo Hu, Xianmin Xia, Aiwu Cheng, et al.
BMC Medical Genomics|November 5, 2020
Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscapeTito Fojo, Lyn Huff, Thomas Litman, et al.
Molecular Cancer Therapeutics|February 20, 2007
The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systemsMerrill E Goldsmith, Alian Aguila, Kenneth Steadman, et al.
Frontiers in Oncology|July 15, 2014
External beam radiation therapy in treatment of malignant pheochromocytoma and paragangliomaJennifer Vogel, Aileen Sia Atanacio, Tamara Prodanov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2016
Adrenocortical Cancer: A Molecularly Complex Disease Where Surgery MattersEden C Payabyab, Sanjeeve Balasubramaniam, Maureen Edgerly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2013
New syndrome of paraganglioma and somatostatinoma associated with polycythemiaKarel Pacak, Ivana Jochmanova, Tamara Prodanov, et al.
BMC Cancer|July 23, 2014
The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort studyJan Schovanek, Victoria Martucci, Robert Wesley, et al.
Plos One|October 6, 2017
Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS statusKrastan B Blagoev, Julia Wilkerson, Mauricio Burotto, et al.
Molecular Cancer Therapeutics|December 7, 2002
Conservation of the class I beta-tubulin gene in human populations and lack of mutations in lung cancers and paclitaxel-resistant ovarian cancersSanja Sale, Raphael Sung, Peidong Shen, et al.
Cancers|October 28, 2023
Novel Therapeutic Strategies Exploiting the Unique Properties of Neuroendocrine NeoplasmsMaryam Safari, Luigi Scotto, Thomas Litman, et al.
Pageof 24

Showing results (161-170 of 237) with videos related to

Sort By:
Pageof 24
Molecular Cancer Therapeutics|December 17, 2008
A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapyJunbo Hu, Xianmin Xia, Aiwu Cheng, et al.
BMC Medical Genomics|November 5, 2020
Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscapeTito Fojo, Lyn Huff, Thomas Litman, et al.
Molecular Cancer Therapeutics|February 20, 2007
The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systemsMerrill E Goldsmith, Alian Aguila, Kenneth Steadman, et al.
Frontiers in Oncology|July 15, 2014
External beam radiation therapy in treatment of malignant pheochromocytoma and paragangliomaJennifer Vogel, Aileen Sia Atanacio, Tamara Prodanov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2016
Adrenocortical Cancer: A Molecularly Complex Disease Where Surgery MattersEden C Payabyab, Sanjeeve Balasubramaniam, Maureen Edgerly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2013
New syndrome of paraganglioma and somatostatinoma associated with polycythemiaKarel Pacak, Ivana Jochmanova, Tamara Prodanov, et al.
BMC Cancer|July 23, 2014
The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort studyJan Schovanek, Victoria Martucci, Robert Wesley, et al.
Plos One|October 6, 2017
Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS statusKrastan B Blagoev, Julia Wilkerson, Mauricio Burotto, et al.
Molecular Cancer Therapeutics|December 7, 2002
Conservation of the class I beta-tubulin gene in human populations and lack of mutations in lung cancers and paclitaxel-resistant ovarian cancersSanja Sale, Raphael Sung, Peidong Shen, et al.
Cancers|October 28, 2023
Novel Therapeutic Strategies Exploiting the Unique Properties of Neuroendocrine NeoplasmsMaryam Safari, Luigi Scotto, Thomas Litman, et al.
Pageof 24